High Tower Advisors, LLC Vaxxinity, Inc. Transaction History

High Tower Advisors, LLC

  • $64.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$0.62 - $0.86 $2,958 - $4,103
-4,772 Reduced 21.62%
17,304 $12,000
Q4 2023

Feb 12, 2024
BUY
$0.7 - $1.31 $15,453 - $28,919
22,076 New
22,076 $18,000
Q2 2022

Aug 10, 2022
BUY
$1.55 - $6.95 $16,248 - $72,856
10,483 New
10,483 $16,000

Others Institutions Holding VAXX

# of Institutions
7
Shares Held
287K
Call Options Held
0
Put Options Held
0
View Full List

About Vaxxinity, Inc.

VAXX Quotes by TradingView
  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email